Publication | Open Access

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Surgical OncologyChemotherapy Versus ChemotherapyGastrointestinal OncologyMedicineGastroenterologyPathologyHer2-positive Advanced GastricCancer TreatmentOncologyRadiation OncologyPhase 3